概述
Non-vitamin K antagonist oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to prevent stroke in patients with atrial fibrillation (AF) and have emerged as the preferred choice, particularly in patients newly started on anticoagulation.1–3 The term NOAC has been used for many years, is used by the current European Society of Cardiology (ESC) AF guidelines3 and is widely recognized.